INDV
INDV
NASDAQ · Pharmaceuticals

Indivior Pharmaceuticals Inc

$39.96
+1.64 (+4.28%)
As of Jun 23, 9:55 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +21.4% upside
Low Target $40.68
Average Target $48.50
High Target $71.11
Current Price $39.96
Current
$39.96
Target
$48.50
$40.68 $48.50 avg $71.11
Scenario Analysis
Bear Case
$40.68
1.8%
Low target
Base Case
$48.50
+21.4%
Avg target
Bull Case
$71.11
+78.0%
High target
Risk/Reward
43.3x
Highly favorable
Price in Context
52-Week High
$41.00
-2.5% from high
52-Week Low
$13.45
+197.1% from low
50-Day SMA
$34.90
+14.5% vs SMA
200-Day SMA
$24.61
+62.4% vs SMA
RSI (14)
47.8
Neutral
Target vs 52W High
$48.50
+18.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%